Method for long-term treatment of rosacea
US11426378B2 · kind B2 · utility
3Cited by
7References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 19, 2020 |
| Grant date | Aug 30, 2022 |
| Priority date | — |
| Expiry date | Aug 18, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q19/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A regimen for the long-term therapeutic treatment of rosacea. The regimen includes topically applying a pharmaceutical composition to the skin of a subject. The pharmaceutical composition includes about 1% w/w to about 10% w/w benzoyl peroxide as an active ingredient, and a pharmaceutically acceptable carrier or excipient. The benzoyl peroxide is the only active ingredient in the pharmaceutical composition, and the pharmaceutical composition is applied once daily for a period of about 52 weeks, to achieve, in a group of such subjects, a success rate of about 75%.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.